Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease

MLA

A. Sidney Barritt, et al. “Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease.” Digestive Diseases (Basel, Switzerland), vol. 39, no. 3, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3342387b3c90f0f7840c23bd9f6554b6&authtype=sso&custid=ns315887.

APA

A. Sidney Barritt, Roberto J. Firpi-Morell, Anna S. Lok, Justin Kupec, Andrew M. Moon, Stephanie Watkins, Brent A. Neuschwander-Tetri, Cheryl Schoen, & Huy N. Trinh. (2020). Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. Digestive Diseases (Basel, Switzerland), 39(3).

Chicago

A. Sidney Barritt, Roberto J. Firpi-Morell, Anna S. Lok, Justin Kupec, Andrew M. Moon, Stephanie Watkins, Brent A. Neuschwander-Tetri, Cheryl Schoen, and Huy N. Trinh. 2020. “Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease.” Digestive Diseases (Basel, Switzerland) 39 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3342387b3c90f0f7840c23bd9f6554b6&authtype=sso&custid=ns315887.